ProfoundBio

About:

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Website: https://www.profoundbio.com

Top Investors: OrbiMed, RA Capital Management, Lilly Asia Ventures, HongShan, Janus Henderson Investors

Description:

ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.